Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
International Journal of Clinical Pharmacology and Therapeutics
|
April 1, 1997
Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives
L Endrenyi, L Tothfalusi
International Journal of Clinical Pharmacology and Therapeutics
|
May 3, 2001
Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studies
L Tothfalusi, L Endrenyi
Pharmaceutical Research
|
April 1, 1999
Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalence
L Endrenyi, L Tothfalusi
Statistics in Medicine
|
October 18, 2000
Properties of the estimated variance component for subject-by-formulation interaction in studies of individual bioequivalence
L Endrenyi, N Taback, L Tothfalusi
International Journal of Clinical Pharmacology and Therapeutics
|
June 5, 2003
Scaling or wider bioequivalence limits for highly variable drugs and for the special case of C(max)
L Tothfalusi, L Endrenyi, K K Midha
Pharmaceutical Research
|
July 11, 2000
Sensitivity of empirical metrics of rate of absorption in bioequivalence studies
A Ring, L Tothfalusi, L Endrenyi, et al.
Pharmaceutical Research
|
August 26, 1998
Metrics comparing simulated early concentration profiles for the determination of bioequivalence
L Endrenyi, F Csizmadia, L Tothfalusi, et al.
Pharmaceutical Research
|
May 1, 1998
The duration of measuring partial AUCs for the assessment of bioequivalence
L Endrenyi, F Csizmadia, L Tothfalusi, et al.
Pharmaceutical Research
|
July 28, 2001
Evaluation of the bioequivalence of highly-variable drugs and drug products
L Tothfalusi, L Endrenyi, K K Midha, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence
M Arato, E Frecska, D J Maccrimmon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
International Journal of Clinical Pharmacology and Therapeutics
|
April 1, 1997
Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives
L Endrenyi, L Tothfalusi
International Journal of Clinical Pharmacology and Therapeutics
|
May 3, 2001
Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studies
L Tothfalusi, L Endrenyi
Pharmaceutical Research
|
April 1, 1999
Subject-by-formulation interaction in determinations of individual bioequivalence: bias and prevalence
L Endrenyi, L Tothfalusi
Statistics in Medicine
|
October 18, 2000
Properties of the estimated variance component for subject-by-formulation interaction in studies of individual bioequivalence
L Endrenyi, N Taback, L Tothfalusi
International Journal of Clinical Pharmacology and Therapeutics
|
June 5, 2003
Scaling or wider bioequivalence limits for highly variable drugs and for the special case of C(max)
L Tothfalusi, L Endrenyi, K K Midha
Pharmaceutical Research
|
July 11, 2000
Sensitivity of empirical metrics of rate of absorption in bioequivalence studies
A Ring, L Tothfalusi, L Endrenyi, et al.
Pharmaceutical Research
|
August 26, 1998
Metrics comparing simulated early concentration profiles for the determination of bioequivalence
L Endrenyi, F Csizmadia, L Tothfalusi, et al.
Pharmaceutical Research
|
May 1, 1998
The duration of measuring partial AUCs for the assessment of bioequivalence
L Endrenyi, F Csizmadia, L Tothfalusi, et al.
Pharmaceutical Research
|
July 28, 2001
Evaluation of the bioequivalence of highly-variable drugs and drug products
L Tothfalusi, L Endrenyi, K K Midha, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1991
Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence
M Arato, E Frecska, D J Maccrimmon, et al.
Page
of 2